Another DSO Open MIC session is in the books! Thank you for attending today's afternoon session. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/poap-tc

Thank you for attending today's DT & IT Pharma Townhall! Looking at the past year with excitement and much to learn, we came together for the following agenda: - Opening Bijoy & Patrick with Q&A (30 min)​ - PH IT Award 2023 celebration with Bijoy and the LT (25 min)​ - OKR 2024 (20 min)​ - Q&A (15 min) Curious who won the PH IT Award 2023?? Well, here we go! Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Rare diseases are defined by their low prevalence in the population, leading to challenges in diagnosis, research, and treatment. Definitions vary; in the US, a disease is rare if it affects fewer than 1:1,500 individuals, Europe 1:2,000, Japan 1:2,500. There are some 7,000 rare diseases, impacting around 6-8% of the world at some point, some 300 million currently. They are incredibly diverse, ranging from genetic disorders to rare cancers, and can be chronic, progressive, debilitating, and often life-threatening. Some well-known rare diseases include cystic fibrosis, Duchenne muscular dystrophy, and Huntington's disease, each with their own unique symptoms, treatment challenges, and research needs. Rare diseases are closely related to orphan diseases, a term that originally referred to diseases neglected by drug developers due to the small market potential. However, the terms are now often used interchangeably. Legislation such as the Orphan Drug Act of 1983 in the U.S. has incentivized pharmaceutical companies to develop treatments for rare (orphan) diseases, offering benefits like tax credits and exclusive marketing rights. The rarity and diversity of these diseases pose significant hurdles for research and clinical trials, Raising awareness and support for those affected are crucial for research funding to develop diagnostics, treatments, and hopefully cures. https://en.wikipedia.org/wiki/Rare_disease Art+Text supported by ChatGPT

Welcome to the heart of innovation – the Berlin Campus, a distinguished hub for science, technology, and groundbreaking advancements. Join us on February 27, 2024, starting at 13:00, for an extraordinary event that transcends boundaries and redefines possibilities. Thank you for attending the Umweltschutz booth! Your presence and active engagement helped us shape the success of this event. Never forget why we are doing what we are doing: together, we redefine the future of science, technology, and innovation. Bayer terms & conditions apply: POAP Terms & Conditions | Bayer Global